The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.

A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.

Zhitong FinanceApr 26 11:38

CONSUN PHARMA (01681.HK) has obtained approval to conduct clinical trials for its kidney disease treatment drugs in China.

CONSUN PHARMA (01681.HK) announced that it has received the approval notice for the clinical trial of the 'SK-09' tablet issued by the National Medical Products Administration. The drug is intended for the treatment of foot cell injury-related kidney diseases, such as diabetic nephropathy, focal segmental glomerulosclerosis, and minimal change disease.

AASTOCKSApr 25 16:48

CONSUN PHARMA (01681) received the "Drug Clinical Trial Approval Notification" for SK-09 tablets.

CONSUN PHARMA (01681) announced that the company has received the relevant SK-09 tablet issued by the National Medical Products Administration of China...

Zhitong FinanceApr 25 16:45

Southbound capital continues to flow in, making the Hong Kong stock market's Innovative Drugs Sector a "favorite".

With the recent easing of the external environment and its bullish effects, the Hong Kong stock market's Innovative Drugs sector has rebounded rapidly.

Zhitong FinanceApr 25 16:04

Accelerating recovery? In March, domestic Innovative Drugs investment and financing increased by about 50% year-on-year, and the Hong Kong Stock pharmaceutical Sector collectively surged.

① In March, domestic investment and financing for Innovative Drugs increased by approximately fifty percent year-on-year, how significant is the Bullish impact? ② The Hong Kong stock market's pharmaceutical Sector rose collectively, which stocks are attracting market attention?

cls.cnApr 24 15:37

The trial for importing beef gallbladder has been opened, causing a significant drop in the prices of the most expensive Traditional Chinese Medicine materials.

① The National Medical Products Administration and the General Administration of Customs recently jointly announced a trial for beef bile from specific countries that meet standards for production in Chinese Patent Medicine. ② The price of natural beef bile (gall bile) has dropped from a peak of 1.8 million yuan per kilogram to 1.4 million to -1.45 million yuan per kilogram.

cls.cnApr 23 22:19